Novo Nordisk, the Danish dr-g manufacturer behind the weight-loss and diabetes dr-g Ozempic and other medications, said it's paying up to $5.2 billion to buy Akero Therapeutics, a biotech company with a dr-g in a late-stage trial to treat a fatal liver disease.
https://www.morningstar.com/news/marketwatch/20251009145/novo-nordisk-is-paying-up-to-52-billion-for-a-san-francisco-biotech-working-on-liver-disease